Prudent use of NSAIDs in patients with covid-19, dengue and chikungunya

Authors

Keywords:

Pain Management, Cautions with SSRIs, Hypertensive Patients with Viral Fever, Misuse of NSAIDs, NSAIDs in Kidney or Liver-compromised Patients

Abstract

NSAIDs are most common pharmacological options for pain management, although their use is questionable in many viral diseases like COVID-19, Dengue, and Chikungunya. Newer studies suggest to limit their use in such cases and also reinforces more careful considerations in patients with liver and kidney injuries or concurrent administration with other drugs/nutraceuticals such as antioxidants or SSRIs.

References

Lucas GNC, Leitão ACC, Alencar RL, Xavier RMF, Daher EF, Silva Junior GBD. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol, 2019; 41(1):124-130. doi: 10.1590/2175-8239-JBN-2018-0107.

Davis, Abigail, John Robson. “The Dangers of Nsaids: Look Both Ways.” British Journal of General Practice, 2016; 66(645):172-173. https://doi.org/10.3399/bjgp16x684433

Mohiuddin Abdul Kader. “Medication Adherence: Fact or Fictions?” Open Journal of Pharmaceutical Science and Research, 2022; 4:6-10. https://doi.org/https://doi.org/10.36811/ojpsr.2022.110017.https://www.raftpubs.com/ojpsr-pharmaceutical-science-and-research/pdf/ojpsr_raft1017.pdf

Esposito Pasquale et al. “Changes of Acute Kidney Injury Epidemiology during the COVID-19 Pandemic: A Retrospective Cohort Study.” Journal of Clinical Medicine, 2022; 11(12):3349. doi:10.3390/jcm11123349

Gabrielli M, Franza L, Esperide A, Gasparrini I, Gasbarrini A, Franceschi F. On behalf of GEMELLI AGAINST COVID 2019. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy. Vaccines, 2022: 10:192. https://doi.org/10.3390/vaccines10020192

Peng Mei, et al. “Role of Hypertension on the Severity of COVID-19: A Review.” Journal of Cardiovascular Pharmacology, 2021; 78(5):e648-e655. doi:10.1097/FJC.0000000000001116

Sharp TM, Keating MK, Shieh WJ, Bhatnagar J, Bollweg BC, Levine R, et al. Clinical Characteristics, Histopathology, and Tissue Immunolocalization of Chikungunya Virus Antigen in Fatal Cases. Clin Infect Dis, 2021; 73(2):e345-e354. doi: 10.1093/cid/ciaa837

Stöllberger C, Finsterer J. Nonsteroidal anti-inflammatory drugs in patients with cardio- or cerebrovascular disorders. Z Kardiol, 2003; 92(9):721-9. doi: 10.1007/s00392-003-0964-x.

Alam SM, Qasswal M, Ahsan MJ, Walters RW, Chandra S. Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis. Sci Rep, 2022; 12(1):14452. doi: 10.1038/s41598-022-18654-2.

Mohiuddin AK. “Chapter 29. Non-Drug Pain Management”. The Role of the Pharmacist in Patient Care: Achieving High Quality, Cost-Effective and Accessible Healthcare Through a Team-Based, Patient-Centered Approach, Universal-Publishers, 2020, p570-19. https://www.universal-publishers.com/book.php?method=ISBN&book=1627343083.

Downloads

Published

2021-11-03

How to Cite

[1]
A. K. Mohiuddin, “Prudent use of NSAIDs in patients with covid-19, dengue and chikungunya”, J. A. Med. Sci, vol. 1, no. 2, pp. 12–13, Nov. 2021.

Issue

Vol. 1 No. 2 (2021)

Section

Articles

License

Copyright (c) 2021 Abdul Kader Mohiuddin

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.